WealthPLAN Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$942K Sell
785
-15
-2% -$15.3K 0.18% 110
2026
Q1
$736K Sell
800
-1,429
-64% -$1.45M 0.14% 132
2025
Q4
$2.4M Sell
2,229
-994
-31% -$950K 0.36% 83
2025
Q3
$2.46M Buy
3,223
+1,383
+75% +$1.03M 0.37% 88
2025
Q2
$1.43M Sell
1,840
-158
-8% -$123K 0.23% 103
2025
Q1
$1.65M Buy
1,998
+75
+4% +$62.4K 0.23% 99
2024
Q4
$1.48M Buy
1,923
+155
+9% +$128K 0.21% 106
2024
Q3
$1.57M Buy
1,768
+187
+12% +$168K 0.21% 107
2024
Q2
$1.43M Buy
1,581
+3
+0.2% +$2.4K 0.15% 126
2024
Q1
$1.23M Buy
1,578
+5
+0.3% +$3.56K 0.13% 144
2023
Q4
$917K Hold
1,573
0.09% 160
2023
Q3
$845K Buy
1,573
+219
+16% +$113K 0.1% 155
2023
Q2
$635K Sell
1,354
-190
-12% -$79.7K 0.09% 166
2023
Q1
$530K Sell
1,544
-2,148
-58% -$724K 0.06% 187
2022
Q4
$1.28M Buy
+3,692
New +$1.31M 0.09% 161
2022
Q1
$941K Buy
3,222
+225
+8% +$57.9K 0.07% 179
2021
Q4
$735K Buy
2,997
+766
+34% +$194K 0.05% 214
2021
Q3
$547K Buy
2,231
+1,164
+109% +$287K 0.04% 242
2021
Q2
$282K Buy
+1,067
New +$214K 0.02% 302
2017
Q2
Sell
-466
Closed -$39.9K 323
2017
Q1
$39.9K Buy
+466
New +$37.3K 0.14% 129
2016
Q3
$54.7K Sell
675
-175
-21% -$14K 0.02% 319
2016
Q2
$53.2K Buy
+850
New +$64K 0.01% 887
2015
Q4
$50.8K Buy
+3,000
New +$249K 0.01% 620

Other funds holding LLY

WealthPLAN Partners's LLY Position: Q2 2026 in Review

WealthPLAN Partners reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $15.3K and leaving 785 shares worth $942K. The position accounts for 0.18% of the portfolio, ranked #110.

WealthPLAN Partners first reported a position in LLY in Q4 2015 and has held it in 23 quarters since. The position peaked at $2.46M in Q3 2025. 1,778 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WealthPLAN Partners held 785 shares of Eli Lilly worth $942K as of Q2 2026.
  • WealthPLAN Partners sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.18% of WealthPLAN Partners's portfolio in Q2 2026, its #110 holding.
  • WealthPLAN Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 23 quarters since.
  • WealthPLAN Partners's Eli Lilly position peaked at $2.46M in Q3 2025.
  • 1,778 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.